Reportlinker Adds Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

News provided by

Apr 26, 2010, 12:47 ET

NEW YORK, April 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

http://www.reportlinker.com/p0190594/Global-Drug-Eluting-Balloons-DEB-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html

Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Summary

GlobalData's report, "Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global drug eluting balloons (DEB) market, a key segment within the medical device industry. The report provides market landscape, competitive landscape and market trends information the drug eluting balloons (DEB) market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. Drug Eluting Balloons (DEB) have recently come into the limelight following the Conformite Europeenne (CE) approval of several DEB products and their consequent launch in Europe. The recently concluded clinical trials in Europe have produced superior results to the current interventions for a large number of indications such as in-stent restenosis, peripheral vascular disease and bifurcation lesions. The global drug eluting balloons (DEBs) market was valued at $60m in 2009 and is expected to be driven by increased adoption by physicians as long term clinical data is released, and as the device is adopted for newer indications such as peripheral vascular disease.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the drug eluting balloons (DEB) market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Aachen Resonance, B. Braun, Bayer, Caliber Therapeutics, Cook Medical, Eurocor, Invatec and Lutonix.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the drug eluting balloons (DEB) market globally.

- Design and develop your product development, marketing and sales strategies.

- Exploit M&A opportunities by identifying market players with the most innovative pipeline.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next being thing in the drug eluting balloons (DEB) market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global drug eluting balloons (DEB) market and the factors shaping it.

To order this report:

: Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!